Amperos Health raises $16M Series A for AI-powered denial management platform

Amperos Health secured $16 million in Series A funding led by Bessemer Venture Partners to scale its AI-powered denial management platform. The company's software uses large language models to automate the identification, analysis, and appeal of claim denials. This capital infusion signals continued investor and provider interest in automating high-touch, labor-intensive RCM tasks. While the platform is in early stages, its development reflects a broader industry trend toward using AI to address rising denial rates and shrinking margins.